19 Dec 2011 Selexys Pharmaceuticals Completes Phase I Clinical Study for Sickle Cell Drug
17 Dec 2011 ThromboGenics and BioInvent Complete Enrolment of Phase IIb Trial with TB-402 ahead of schedule
17 Dec 2011 AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
15 Dec 2011 Human Genome Sciences and GlaxoSmithKline Initiate Phase 3 Trial of Belimumab (BENLYSTA®) Administered Subcutaneously in Subjects with Systemic Lupus Erythematosus
14 Dec 2011 Clinical development of BT-062 in multiple myeloma expands into combination therapy
14 Dec 2011 Genentech Initiates First-in-Human Study with NovImmune’s Anti-IL17 Antibody
14 Dec 2011 Immunomedics Announces Results From Two Clinical Trials at Hematology Conference
14 Dec 2011 Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses
14 Dec 2011 Seattle Genetics and Millennium Report Data from Phase I Trial of ADCETRIS™ (Brentuximab Vedotin) in Front-line Hodgkin Lymphoma at ASH Annual Meeting
14 Dec 2011 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers
14 Dec 2011 Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
13 Dec 2011 Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS™ (Brentuximab Vedotin) in Relapsed or Refractory Systemic ALCL at ASH Annual Meeting
13 Dec 2011 Symphogen Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at ASH
13 Dec 2011 Immunomedics Develops Novel Antibody-Based Therapeutics for Mantle Cell and Other Lymphomas
13 Dec 2011 Ablynx Initiates Phase I Study With ALX-0171 for the Treatment of Respiratory Syncytial Virus (RSV)
12 Dec 2011 Micromet’s Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia
12 Dec 2011 Celldex Therapeutics Presents Novel Preclinical Data on CDX-1127 at the American Society of Hematology Meeting in San Diego
12 Dec 2011 Anti-cancer activity of BI-505 demonstrated in animal model
12 Dec 2011 Impressive ZEVALIN(R) Data Highlighted at 53rd Annual Meeting of the American Society of Hematology; Spectrum to Increase Clinical Efforts to Expand ZEVALIN Indications
11 Dec 2011 Genmab Announces Preliminary Safety and Efficacy Data for Daratumumab
11 Dec 2011 Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients
08 Dec 2011 Genentech Announces Positive Results of Pivotal Phase III Study with pertuzumab in HER2-Positive Metastatic Breast Cancer
07 Dec 2011 Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim
07 Dec 2011 Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up